Utilizing the Lung as a Model to Study Nanoparticle-Based Drug Delivery Systems View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2018-07-27

AUTHORS

Dylan K. McDaniel , Veronica M. Ringel-Scaia , Sheryl L. Coutermarsh-Ott , Irving C. Allen

ABSTRACT

Intranasal administration is a highly effective route for drug delivery and biodistribution studies. Indeed, this route of delivery has become the method of choice to distribute diverse pharmacological agents both locally and systemically. In the majority of preclinical animal models and in human patients, intranasal administration is the preferred method to deliver therapeutic agents to the airways and lungs. However, issues with drug stability and controlled release in the respiratory tract are common problems with many therapeutic agents. Nanoparticle delivery via intranasal administration has tremendous potential to circumvent these common issues. Over the past 30 years nanoparticles have gained increased interest as therapeutic delivery vehicles and as tools for improved bioimaging. Integral to the success of nanoparticles in drug delivery and biodistribution is the utilization of mouse models to characterize therapeutic strategies under physiologically relevant in situ conditions. Here, we describe a model of nanoparticle administration to the lungs utilizing intranasal administration and discuss a variety of highly useful techniques to evaluate nanoparticle up-take, biodistribution, and immune response. While these protocols have been optimized for intranasal administration of common fluorescently labeled nanoparticles, they can be applied to any nanoparticle or drug delivery system of interest targeting the lungs and airways. More... »

PAGES

179-190

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4939-8661-3_13

DOI

http://dx.doi.org/10.1007/978-1-4939-8661-3_13

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1105855529

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30051432


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Intranasal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Delivery Systems", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Flow Cytometry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorescent Dyes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Biological", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanoparticles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tissue Distribution", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Virginia\u2013Maryland College of Veterinary Medicine", 
          "id": "https://www.grid.ac/institutes/grid.470073.7", 
          "name": [
            "Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McDaniel", 
        "givenName": "Dylan K.", 
        "id": "sg:person.01233627070.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233627070.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Virginia Tech", 
          "id": "https://www.grid.ac/institutes/grid.438526.e", 
          "name": [
            "Graduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ringel-Scaia", 
        "givenName": "Veronica M.", 
        "id": "sg:person.012206152065.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012206152065.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Virginia\u2013Maryland College of Veterinary Medicine", 
          "id": "https://www.grid.ac/institutes/grid.470073.7", 
          "name": [
            "Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Coutermarsh-Ott", 
        "givenName": "Sheryl L.", 
        "id": "sg:person.01372277546.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372277546.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Virginia Tech", 
          "id": "https://www.grid.ac/institutes/grid.438526.e", 
          "name": [
            "Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, USA", 
            "Graduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, USA", 
            "Department of Biomedical Sciences, Carilion School of Medicine, Virginia Tech, Roanoke, VA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Allen", 
        "givenName": "Irving C.", 
        "id": "sg:person.01117764143.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117764143.98"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11095-016-1875-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004259589", 
          "https://doi.org/10.1007/s11095-016-1875-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.1502281112", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004913512"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pharmthera.2012.03.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016758264"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.nano.2015.11.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017483204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.nano.2015.11.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017483204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.nano.2015.11.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017483204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.nano.2015.11.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017483204"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.nano.2015.01.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027272416"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13346-012-0108-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032684388", 
          "https://doi.org/10.1007/s13346-012-0108-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4155/tde.12.127", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042495726"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jconrel.2014.01.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049690212"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpb.2014.03.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052349460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0062115", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053081540"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/b:phar.0000026823.82950.ff", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053404000", 
          "https://doi.org/10.1023/b:phar.0000026823.82950.ff"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-07-27", 
    "datePublishedReg": "2018-07-27", 
    "description": "Intranasal administration is a highly effective route for drug delivery and biodistribution studies. Indeed, this route of delivery has become the method of choice to distribute diverse pharmacological agents both locally and systemically. In the majority of preclinical animal models and in human patients, intranasal administration is the preferred method to deliver therapeutic agents to the airways and lungs. However, issues with drug stability and controlled release in the respiratory tract are common problems with many therapeutic agents. Nanoparticle delivery via intranasal administration has tremendous potential to circumvent these common issues. Over the past 30\u00a0years nanoparticles have gained increased interest as therapeutic delivery vehicles and as tools for improved bioimaging. Integral to the success of nanoparticles in drug delivery and biodistribution is the utilization of mouse models to characterize therapeutic strategies under physiologically relevant in situ conditions. Here, we describe a model of nanoparticle administration to the lungs utilizing intranasal administration and discuss a variety of highly useful techniques to evaluate nanoparticle up-take, biodistribution, and immune response. While these protocols have been optimized for intranasal administration of common fluorescently labeled nanoparticles, they can be applied to any nanoparticle or drug delivery system of interest targeting the lungs and airways.", 
    "editor": [
      {
        "familyName": "Sirianni", 
        "givenName": "Rachael W.", 
        "type": "Person"
      }, 
      {
        "familyName": "Behkam", 
        "givenName": "Bahareh", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4939-8661-3_13", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4939-8659-0", 
        "978-1-4939-8661-3"
      ], 
      "name": "Targeted Drug Delivery", 
      "type": "Book"
    }, 
    "name": "Utilizing the Lung as a Model to Study Nanoparticle-Based Drug Delivery Systems", 
    "pagination": "179-190", 
    "productId": [
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30051432"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1105855529"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4939-8661-3_13"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "765347ec5cac957a4b2f0ffd3e9dc1d01d00632a4775f4e3ffd81dfca914a2f4"
        ]
      }
    ], 
    "publisher": {
      "location": "New York, NY", 
      "name": "Springer US", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4939-8661-3_13", 
      "https://app.dimensions.ai/details/publication/pub.1105855529"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2019-04-16T09:41", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000374_0000000374/records_119730_00000001.jsonl", 
    "type": "Chapter", 
    "url": "https://link.springer.com/10.1007%2F978-1-4939-8661-3_13"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4939-8661-3_13'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4939-8661-3_13'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4939-8661-3_13'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4939-8661-3_13'


 

This table displays all metadata directly associated to this object as RDF triples.

188 TRIPLES      23 PREDICATES      51 URIs      33 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4939-8661-3_13 schema:about N26d3492db81c49e185a63057bdfd8f1d
2 N3af0f5f0aa4643678fbc47713ebeee5a
3 N45fa06817ad94883846a673b731a14db
4 N54c1edf8cf93411d98b52d321b54ae81
5 N58982a7c1de1433390881fd908c23360
6 N69269b2bf6784243af86843470d41573
7 N89812487315b4ae4833f314b34cabed6
8 N9cc8c9de84d242579674b23ea6df9f3a
9 Na1908935055549328cc643c50259173b
10 Na93a0887206145a08fef3a206d14471b
11 Ne660dcad4fec47ed9510aea5fa18f4a8
12 Nfcfa49fa5690469a8bd64f7979013f2d
13 Nff889d18803344b395c729e84cb5b14e
14 anzsrc-for:11
15 anzsrc-for:1115
16 schema:author N97e2f85abcdd464595723aae49d64e3f
17 schema:citation sg:pub.10.1007/s11095-016-1875-7
18 sg:pub.10.1007/s13346-012-0108-9
19 sg:pub.10.1023/b:phar.0000026823.82950.ff
20 https://doi.org/10.1016/j.ejpb.2014.03.004
21 https://doi.org/10.1016/j.jconrel.2014.01.007
22 https://doi.org/10.1016/j.nano.2015.01.007
23 https://doi.org/10.1016/j.nano.2015.11.002
24 https://doi.org/10.1016/j.pharmthera.2012.03.003
25 https://doi.org/10.1073/pnas.1502281112
26 https://doi.org/10.1371/journal.pone.0062115
27 https://doi.org/10.4155/tde.12.127
28 schema:datePublished 2018-07-27
29 schema:datePublishedReg 2018-07-27
30 schema:description Intranasal administration is a highly effective route for drug delivery and biodistribution studies. Indeed, this route of delivery has become the method of choice to distribute diverse pharmacological agents both locally and systemically. In the majority of preclinical animal models and in human patients, intranasal administration is the preferred method to deliver therapeutic agents to the airways and lungs. However, issues with drug stability and controlled release in the respiratory tract are common problems with many therapeutic agents. Nanoparticle delivery via intranasal administration has tremendous potential to circumvent these common issues. Over the past 30 years nanoparticles have gained increased interest as therapeutic delivery vehicles and as tools for improved bioimaging. Integral to the success of nanoparticles in drug delivery and biodistribution is the utilization of mouse models to characterize therapeutic strategies under physiologically relevant in situ conditions. Here, we describe a model of nanoparticle administration to the lungs utilizing intranasal administration and discuss a variety of highly useful techniques to evaluate nanoparticle up-take, biodistribution, and immune response. While these protocols have been optimized for intranasal administration of common fluorescently labeled nanoparticles, they can be applied to any nanoparticle or drug delivery system of interest targeting the lungs and airways.
31 schema:editor Nd099a791c68b4cd5ad814f74c668ac82
32 schema:genre chapter
33 schema:inLanguage en
34 schema:isAccessibleForFree false
35 schema:isPartOf N32ec98bb4a1048c9b03a9c4be0bd7b04
36 schema:name Utilizing the Lung as a Model to Study Nanoparticle-Based Drug Delivery Systems
37 schema:pagination 179-190
38 schema:productId N1bd87c5f269e413ab7860ecde4090d3c
39 N5878ba36279c459aa7e334f3cd5b8801
40 Na04e1e90df8b48a6b68ffe12f6cd84f8
41 Nc15898a5d37b4976b371c9d7fd0f7fea
42 schema:publisher Nb904874068c84255a301adaf1325dca8
43 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105855529
44 https://doi.org/10.1007/978-1-4939-8661-3_13
45 schema:sdDatePublished 2019-04-16T09:41
46 schema:sdLicense https://scigraph.springernature.com/explorer/license/
47 schema:sdPublisher N74403e2608014abf85dc7f9454995d56
48 schema:url https://link.springer.com/10.1007%2F978-1-4939-8661-3_13
49 sgo:license sg:explorer/license/
50 sgo:sdDataset chapters
51 rdf:type schema:Chapter
52 N1bd87c5f269e413ab7860ecde4090d3c schema:name dimensions_id
53 schema:value pub.1105855529
54 rdf:type schema:PropertyValue
55 N26d3492db81c49e185a63057bdfd8f1d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
56 schema:name Male
57 rdf:type schema:DefinedTerm
58 N32ec98bb4a1048c9b03a9c4be0bd7b04 schema:isbn 978-1-4939-8659-0
59 978-1-4939-8661-3
60 schema:name Targeted Drug Delivery
61 rdf:type schema:Book
62 N3af0f5f0aa4643678fbc47713ebeee5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Flow Cytometry
64 rdf:type schema:DefinedTerm
65 N3d39256a32b94eb9b6d0b651a263e0ff rdf:first sg:person.012206152065.71
66 rdf:rest Nf5cf66c855cb412288b5212f3abe877f
67 N45fa06817ad94883846a673b731a14db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Fluorescent Dyes
69 rdf:type schema:DefinedTerm
70 N4f6453f6d0bd46b08e726ce5c25a977f rdf:first sg:person.01117764143.98
71 rdf:rest rdf:nil
72 N54c1edf8cf93411d98b52d321b54ae81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Tissue Distribution
74 rdf:type schema:DefinedTerm
75 N5878ba36279c459aa7e334f3cd5b8801 schema:name pubmed_id
76 schema:value 30051432
77 rdf:type schema:PropertyValue
78 N58982a7c1de1433390881fd908c23360 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Lung
80 rdf:type schema:DefinedTerm
81 N69269b2bf6784243af86843470d41573 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Animals
83 rdf:type schema:DefinedTerm
84 N74403e2608014abf85dc7f9454995d56 schema:name Springer Nature - SN SciGraph project
85 rdf:type schema:Organization
86 N89812487315b4ae4833f314b34cabed6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Models, Biological
88 rdf:type schema:DefinedTerm
89 N97e2f85abcdd464595723aae49d64e3f rdf:first sg:person.01233627070.01
90 rdf:rest N3d39256a32b94eb9b6d0b651a263e0ff
91 N9cc8c9de84d242579674b23ea6df9f3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Administration, Intranasal
93 rdf:type schema:DefinedTerm
94 Na04e1e90df8b48a6b68ffe12f6cd84f8 schema:name readcube_id
95 schema:value 765347ec5cac957a4b2f0ffd3e9dc1d01d00632a4775f4e3ffd81dfca914a2f4
96 rdf:type schema:PropertyValue
97 Na1908935055549328cc643c50259173b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Female
99 rdf:type schema:DefinedTerm
100 Na93a0887206145a08fef3a206d14471b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Drug Delivery Systems
102 rdf:type schema:DefinedTerm
103 Naa4c1dd046484ddabeea113a714d633a rdf:first Nd97e0d610d95474583096c1c29eb6ed0
104 rdf:rest rdf:nil
105 Nb904874068c84255a301adaf1325dca8 schema:location New York, NY
106 schema:name Springer US
107 rdf:type schema:Organisation
108 Nc13f06f3d34748d88b465897376a5641 schema:familyName Sirianni
109 schema:givenName Rachael W.
110 rdf:type schema:Person
111 Nc15898a5d37b4976b371c9d7fd0f7fea schema:name doi
112 schema:value 10.1007/978-1-4939-8661-3_13
113 rdf:type schema:PropertyValue
114 Nd099a791c68b4cd5ad814f74c668ac82 rdf:first Nc13f06f3d34748d88b465897376a5641
115 rdf:rest Naa4c1dd046484ddabeea113a714d633a
116 Nd97e0d610d95474583096c1c29eb6ed0 schema:familyName Behkam
117 schema:givenName Bahareh
118 rdf:type schema:Person
119 Ne660dcad4fec47ed9510aea5fa18f4a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Nanoparticles
121 rdf:type schema:DefinedTerm
122 Nf5cf66c855cb412288b5212f3abe877f rdf:first sg:person.01372277546.20
123 rdf:rest N4f6453f6d0bd46b08e726ce5c25a977f
124 Nfcfa49fa5690469a8bd64f7979013f2d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Mice
126 rdf:type schema:DefinedTerm
127 Nff889d18803344b395c729e84cb5b14e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Immunity
129 rdf:type schema:DefinedTerm
130 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
131 schema:name Medical and Health Sciences
132 rdf:type schema:DefinedTerm
133 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
134 schema:name Pharmacology and Pharmaceutical Sciences
135 rdf:type schema:DefinedTerm
136 sg:person.01117764143.98 schema:affiliation https://www.grid.ac/institutes/grid.438526.e
137 schema:familyName Allen
138 schema:givenName Irving C.
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117764143.98
140 rdf:type schema:Person
141 sg:person.012206152065.71 schema:affiliation https://www.grid.ac/institutes/grid.438526.e
142 schema:familyName Ringel-Scaia
143 schema:givenName Veronica M.
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012206152065.71
145 rdf:type schema:Person
146 sg:person.01233627070.01 schema:affiliation https://www.grid.ac/institutes/grid.470073.7
147 schema:familyName McDaniel
148 schema:givenName Dylan K.
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233627070.01
150 rdf:type schema:Person
151 sg:person.01372277546.20 schema:affiliation https://www.grid.ac/institutes/grid.470073.7
152 schema:familyName Coutermarsh-Ott
153 schema:givenName Sheryl L.
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372277546.20
155 rdf:type schema:Person
156 sg:pub.10.1007/s11095-016-1875-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004259589
157 https://doi.org/10.1007/s11095-016-1875-7
158 rdf:type schema:CreativeWork
159 sg:pub.10.1007/s13346-012-0108-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032684388
160 https://doi.org/10.1007/s13346-012-0108-9
161 rdf:type schema:CreativeWork
162 sg:pub.10.1023/b:phar.0000026823.82950.ff schema:sameAs https://app.dimensions.ai/details/publication/pub.1053404000
163 https://doi.org/10.1023/b:phar.0000026823.82950.ff
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1016/j.ejpb.2014.03.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052349460
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1016/j.jconrel.2014.01.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049690212
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1016/j.nano.2015.01.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027272416
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1016/j.nano.2015.11.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017483204
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1016/j.pharmthera.2012.03.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016758264
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1073/pnas.1502281112 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004913512
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1371/journal.pone.0062115 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053081540
178 rdf:type schema:CreativeWork
179 https://doi.org/10.4155/tde.12.127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042495726
180 rdf:type schema:CreativeWork
181 https://www.grid.ac/institutes/grid.438526.e schema:alternateName Virginia Tech
182 schema:name Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, USA
183 Department of Biomedical Sciences, Carilion School of Medicine, Virginia Tech, Roanoke, VA, USA
184 Graduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, USA
185 rdf:type schema:Organization
186 https://www.grid.ac/institutes/grid.470073.7 schema:alternateName Virginia–Maryland College of Veterinary Medicine
187 schema:name Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, USA
188 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...